Ledgewood Wealth Advisors, LLC Arbutus Biopharma Corp Transaction History
Ledgewood Wealth Advisors, LLC
- $155 Billion
- Q4 2024
A detailed history of Ledgewood Wealth Advisors, LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Ledgewood Wealth Advisors, LLC holds 278,436 shares of ABUS stock, worth $974,526. This represents 0.59% of its overall portfolio holdings.
Number of Shares
278,436Holding current value
$974,526% of portfolio
0.59%Shares
1 transactions
Others Institutions Holding ABUS
# of Institutions
166Shares Held
101MCall Options Held
649KPut Options Held
666K-
Morgan Stanley New York, NY22.6MShares$79.1 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.2MShares$46.3 Million22.74% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$40.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.98MShares$31.4 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.74MShares$30.6 Million4.68% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $525M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...